SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015767
Filing Date
2022-08-09
Accepted
2022-08-09 08:01:07
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20220630.htm   iXBRL 10-Q 2214753
2 EX-10.15 pmvp-ex10_15.htm EX-10.15 39017
3 EX-31.1 pmvp-ex31_1.htm EX-31.1 20307
4 EX-31.2 pmvp-ex31_2.htm EX-31.2 20276
5 EX-32.1 pmvp-ex32_1.htm EX-32.1 11741
6 EX-32.2 pmvp-ex32_2.htm EX-32.2 12329
  Complete submission text file 0000950170-22-015767.txt   7563832

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20220630.xsd EX-101.SCH 42626
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pmvp-20220630_def.xml EX-101.DEF 96480
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pmvp-20220630_cal.xml EX-101.CAL 41117
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20220630_lab.xml EX-101.LAB 342153
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20220630_pre.xml EX-101.PRE 243825
56 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20220630_htm.xml XML 1510755
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 221146474
SIC: 2834 Pharmaceutical Preparations